Drug Pipeline

Young TIL Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-09 NCT02621021
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor…		 Enrollment reduced: 170 -> 53 participants
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT02133196 T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer Advanced Non-Small Cell Lung Cancer Recruiting
NCT02621021 A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor… Melanoma Recruiting
NCT01174121 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer Metastatic Colorectal Cancer Recruiting
Sponsors Running Young TIL Trials
National Cancer Institute (NCI) (3)
Disease Areas
Breast Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Ovarian Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Melanoma (1)
Get alerts when Young TIL trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free